Condition
Periorbital Hyperpigmentation
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07667972Not ApplicableActive Not Recruiting
Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea
NCT05807620Not ApplicableCompletedPrimary
A 12 Week Study to Evaluate the Efficacy of an Eye Cream
NCT04697992Not ApplicableCompletedPrimary
Topical Tranexamic Acid Versus Topical Vitamin C With Microneedling in Periorbital Hyperpigmentation; Comparative Study
NCT03400202CompletedPrimary
Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles
NCT03114514Not ApplicableCompletedPrimary
Efficacy of Platelet-rich Plasma (PRP) in the Treatment of Dark Circles Under the Eyes
Showing all 5 trials